3[1]Huebner J, Goldmann DA. coagulase negative staphylococci: role as pathogens[J]: Annu Rev Med, 1999,50:223-236.
4[2]Noble WC, Pitcher DG. Microbial ecology of the human skin[J]. Adv Microbiol Ecol, 1979,2:245-253.
5[3]Freeman DJ, Falkiner FR, Keane CT. New method for detecting slime production by coagulase negative staphylococci [J]. J Clin Pathol, 1989,42: 872-874.
6[4]Ishak A, Groschel HM, Mandell L, et al. Association of slime with pathogenicity of coagulase-negative staphyococci causing nosocomial septicemia[J]. Microbiology, 1985, 1025-1029.
7[5]Christensen GD, Simpson WA, Bisno AL, et al. Adherence of slime-producing strains of Staphylococcus epidermidis to smooth surfaces[J]. Infect Immun, 1982, 37: 318-326.
8[6]Peters G, Locci R, Pulverer G. Adherence and growth of coagulase-negative staphylococci on surface of intravenous catheters[J]. J Infect Dis, 1982, 146: 479-482.
9[1]Levine C, Hiasa H, Marians K. DNA gyrase and topoisomerase Ⅳ: biochemical activities, physiological roles during chromosome replication, and drug sensitivities [J]. Biochim Biophys Acta,1998,140(3): 29 - 43.
10[2]Schaeffer AJ. The expanding role of fluoroquinolones[ J]. Am J Med,2002,8(7): 113- 115.
4EMORI T G,GAYNES R P.An overview of nosocomial infections including the role of the microbiologylaboratory[J].Clin Microbiol Rev,1993,6(4):428 -442.
5VANPOUCKE H,CLAEYS G,DEGRAUWE E,et al.Comparative in vitro activity of cefepime against strains isolated from intensive care and haematology patients[J].Acta Clin Belg,2000,55(1):16 -21.
6SCHABERGD R,CULVER D H,GAYNES R P.Major trends in the microbial etiology of nosocomial infections[J].Am J Med,1991,91(3B):72.
